NEW YORK (GenomeWeb News) – Health Discovery Corp. said today that it has taken a 15 percent equity stake in Smart Personalized Medicine, a prognostic test start-up founded by Richard Caruso, a former HDC board member and chairman and founder of Integra Life Sciences.
 
HDC said last week that Caruso had resigned his position as a board member to negotiate a license to use the firm’s support vector machine technology in developing a breast cancer prognostic test.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.